B L de Jonge - Concepedia

Author

B L de Jonge

Rockefeller University

Also Known As

B L de Jonge, B.L. de Jonge, Boudewijn L. de Jonge

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Rockefeller University

About

B L de Jonge is an author at Rockefeller University specializing in medicine, microbiology, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	613
2	Health Sciences	8	8	436
3	Biochemistry	7	7	496
4	Natural Sciences	1	1	92
5	Public Health	1	1	85

B L de Jonge

Publications

935

Citations

H-Index

Page 1

	Year	Citations
Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. The role of penicillin binding protein 2A. B L de Jonge, Yoon‐Seok Chang, Douglas A. Gage, Journal of Biological Chemistry	1992	322
Altered muropeptide composition in Staphylococcus aureus strains with an inactivated femA locus B L de Jonge, Thomas Sidow, Yoon‐Seok Chang, Journal of Bacteriology Pentaglycine Cross BridgesBacteriologyInactivated Fema LocusAntimicrobial ChemotherapyDrug Resistance	1993	103
Peptidoglycan composition in heterogeneous Tn551 mutants of a methicillin-resistant Staphylococcus aureus strain. B L de Jonge, Yoon‐Seok Chang, Douglas A. Gage, Journal of Biological Chemistry GlycobiologyBacteriologyAntibiotic ResistanceBacterial PathogensHeterogeneous Tn551 Mutants	1992	94
Peptidoglycan synthesis during the cell cycle of Escherichia coli: composition and mode of insertion B L de Jonge, Frans B. Wientjes, I Jurida, Journal of Bacteriology Bioorganic ChemistryChemical CompositionGlycobiologyMolecular BiologyEscherichia Coli	1989	92
Increased cell size and shortened peptidoglycan interpeptide bridge of NaCl-stressed Staphylococcus aureus and their reversal by glycine betaine U Vijaranakul, Mathew J. Nadakavukaren, B L de Jonge, Journal of Bacteriology GlycobiologyBacteriologyCell CultureCellular PhysiologyDrug Resistance	1995	85
Reduced methicillin resistance in a new Staphylococcus aureus transposon mutant that incorporates muramyl dipeptides into the cell wall peptidoglycan. A Ornelas-Soares, H. DE LENCASTRE, B L de Jonge, Journal of Biological Chemistry Reduced Methicillin ResistanceMolecular BiologyAntibiotic ResistanceBacterial PathogensDrug Resistance	1994	63
Suppression of autolysis and cell wall turnover in heterogeneous Tn551 mutants of a methicillin-resistant Staphylococcus aureus strain B L de Jonge, Hermı́nia de Lencastre, Alexander Tomasz Journal of Bacteriology Antimicrobial Resistance GeneAntimicrobial SusceptibilityHealth SciencesCell Wall TurnoverVirulence Factor	1991	62
Effect of exogenous glycine on peptidoglycan composition and resistance in a methicillin-resistant Staphylococcus aureus strain B L de Jonge, Yoon‐Seok Chang, Naihan Xu, Antimicrobial Agents and Chemotherapy Exogenous GlycineAntimicrobial Resistance GeneD-alanyl-d-alanine-terminating MuropeptidesHealth SciencesBiochemistry	1996	30
Altered peptidoglycan composition in vancomycin-resistant Enterococcus faecalis B L de Jonge, S Handwerger, Douglas A. Gage Antimicrobial Agents and Chemotherapy Antimicrobial Resistance GeneAltered Peptidoglycan CompositionHealth SciencesAntibioticsAntimicrobial Susceptibility	1996	30
Cloning of the Staphylococcus aureus ddh gene encoding NAD+-dependent D-lactate dehydrogenase and insertional inactivation in a glycopeptide-resistant isolate Susan Boyle‐Vavra, B L de Jonge, C C Ebert, Journal of Bacteriology Susceptibility TestingGlycobiologyAntibiotic ResistanceDrug ResistanceNad+-dependent D-lactate Dehydrogenase	1997	29

Page 1